Cargando…
Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study
PURPOSE: To investigate the effect of 21-gene recurrence score (RS) on chemotherapy-decision making and prognosis in breast cancer patients aged <40 years. METHODS: Using the Surveillance, Epidemiology, and End Results program, we included patients aged <40 years with tumor size ≤5 cm, node ne...
Autores principales: | Liu, Kai-Hua, Zhang, Lei, Chen, Jian-Xian, Lian, Chen-Lu, Wang, Jun, He, Zhen-Yu, Wu, San-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375685/ https://www.ncbi.nlm.nih.gov/pubmed/31918322 http://dx.doi.org/10.1016/j.breast.2019.12.013 |
Ejemplares similares
-
The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database
por: Choi, In Sil, et al.
Publicado: (2020) -
The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
por: Wang, Jun, et al.
Publicado: (2019) -
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database
por: Jung, Jiwoong, et al.
Publicado: (2022) -
Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis
por: Zhou, Ping, et al.
Publicado: (2020) -
Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer
por: Wu, San-Gang, et al.
Publicado: (2019)